Michael Bamberg spends much of his time researching Surgery, Radiation therapy, Chemotherapy, Internal medicine and Pathology. Surgery and Clinical trial are frequently intertwined in his study. His Radiation therapy research incorporates themes from Survival analysis, Nuclear medicine and Glioma.
Michael Bamberg has included themes like Concomitant, Primary tumor and Neuroectodermal tumor in his Chemotherapy study. His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Oncology. His research in Pathology intersects with topics in Progenitor cell, Receptor, Cytokine and Cell biology.
Michael Bamberg mostly deals with Radiation therapy, Surgery, Internal medicine, Oncology and Chemotherapy. Michael Bamberg has researched Radiation therapy in several fields, including Stage, Nuclear medicine and Pathology. His work is dedicated to discovering how Pathology, Cancer research are connected with Apoptosis and other disciplines.
His study in the field of Survival rate, Retrospective cohort study, Regimen and Seminoma also crosses realms of Standard treatment. As part of his studies on Internal medicine, Michael Bamberg often connects relevant areas like Gastroenterology. His studies in Chemotherapy integrate themes in fields like Concomitant, Primary tumor and Glioma.
His scientific interests lie mostly in Radiation therapy, Internal medicine, Oncology, Surgery and Chemotherapy. His work carried out in the field of Radiation therapy brings together such families of science as Prostatectomy, Survival analysis, Retrospective cohort study and Intensive care medicine. His work deals with themes such as Follicular lymphoma, Prostate cancer, Toxicity and Temozolomide, which intersect with Oncology.
His studies in Surgery integrate themes in fields like Hyperthermia and Radiology. His Chemotherapy research includes themes of Concomitant, Clinical endpoint and Methotrexate. His Survival rate research is multidisciplinary, incorporating elements of Progressive disease, Combined Modality Therapy and Chemoradiotherapy.
Radiation therapy, Surgery, Internal medicine, Chemotherapy and Oncology are his primary areas of study. The study incorporates disciplines such as Prostate-specific antigen, Prostatectomy, Prostate cancer, Retrospective cohort study and Survival analysis in addition to Radiation therapy. His Surgery study integrates concerns from other disciplines, such as Neoadjuvant therapy, Radiology and Fibrosis.
His Chemotherapy research incorporates themes from Concomitant, Methotrexate, Whole brain radiotherapy and Confidence interval. His biological study spans a wide range of topics, including Mastectomy and Toxicity. He has researched Chemotherapy regimen in several fields, including Primary central nervous system lymphoma, Progression-free survival, Glioma, Pathology and Ifosfamide.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide
Wolfgang Wick;Christian Hartmann;Corinna Engel;Mandy Stoffels.
Journal of Clinical Oncology (2009)
European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I
Susanne Krege;Jörg Beyer;Rainer Souchon;Peter Albers.
European Urology (2008)
High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial
Eckhard Thiel;Agnieszka Korfel;Peter Martus;Lothar Kanz.
Lancet Oncology (2010)
Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.
Rolf D. Kortmann;Joachim Kühl;Beate Timmermann;Uwe Mittler.
International Journal of Radiation Oncology Biology Physics (2000)
Cellular basis of radiation-induced fibrosis
H.Peter Rodemann;Michael Bamberg.
Radiotherapy and Oncology (1995)
Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients
Wilhelm Küker;Thomas Nägele;Agnieska Korfel;Stefan Heckl.
Journal of Neuro-oncology (2005)
Hyperfractionated Accelerated Chemoradiation With Concurrent Fluorouracil-Mitomycin Is More Effective Than Dose-Escalated Hyperfractionated Accelerated Radiation Therapy Alone in Locally Advanced Head and Neck Cancer: Final Results of the Radiotherapy Cooperative Clinical Trials Group of the German Cancer Society 95-06 Prospective Randomized Trial
Volker Budach;Martin Stuschke;Wilfried Budach;Michael Baumann.
Journal of Clinical Oncology (2005)
Radiation induced CNS toxicity – molecular and cellular mechanisms
C Belka;W Budach;R D Kortmann;M Bamberg.
British Journal of Cancer (2001)
Radiation therapy for intracranial germinoma: results of the German cooperative prospective trials MAKEI 83/86/89.
Michael Bamberg;Rolf-D. Kortmann;Gabriele Calaminus;Gerd Becker.
Journal of Clinical Oncology (1999)
Radiotherapy for Stages IIA/B Testicular Seminoma: Final Report of a Prospective Multicenter Clinical Trial
Johannes Classen;Heinz Schmidberger;Christoph Meisner;Rainer Souchon.
Journal of Clinical Oncology (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: